GARFIELD-AF Risk Calculator
Compare the effects of different anticoagulant treatment decisions in atrial fibrillation
Questions
About
The GARFIELD-AF risk calculator was designed to help clinicians assess the future risk of mortality, ischaemic stroke and major bleeding (including haemorrhagic stroke), as a guide to using anticoagulants in patients with a new diagnosis of atrial fibrillation (AF).
It simultaneously provides the risks for up to 24 months of:
- Mortality
- Ischaemic Stroke or Systemic Embolism
- Major Bleeding Incl. Haemorrhagic Stroke
It allows clinicians to compare the effects of different anticoagulant treatment decisions – no oral anticoagulation (no OAC), vitamin K antagonist (VKA), non-vitamin K oral anticoagulant (NOAC) – based on the results from similar patients in the GARFIELD-AF Registry.
It uses routinely collected clinical data and includes a total of 16 questions.
It has been derived from the GARFIELD-AF population and externally validated.
You can find a version of the GARFIELD-AF risk calculator with further features at this link: https://af.garfieldregistry.org/garfield-af-risk-calculator.
References
Fox KAA, Lucas JE, Pieper KS, Bassand J-P, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Oto A, Mantovani LG, Misselwitz F, Piccini JP, Turpie AGG, Verheugt FWA, Kakkar AK.
By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.